Bio Impact Capital LLC Context Therapeutics Inc. Put Options Transaction History
Bio Impact Capital LLC
- $669 Million
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CNTX
# of Institutions
50Shares Held
60.3MCall Options Held
0Put Options Held
0-
Avidity Partners Management LP Dallas, TX7.48MShares$6.13 Million0.84% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$6.08 Million0.32% of portfolio
-
Nextech Invest Ag7.42MShares$6.08 Million1.37% of portfolio
-
Blue Owl Capital Holdings LP New York, NY6.36MShares$5.21 Million2.69% of portfolio
-
Great Point Partners LLC Greenwich, CT4.68MShares$3.84 Million3.06% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $13.1M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...